Introduction

Dynatrace has agreed to acquire Arize AI in a cash-and-stock deal worth $915 million, pairing an established observability platform with a specialist AI evaluation company. DLA Piper advised Arize, the company being bought, on the deal's signing on August 13, 2026, with closing expected in Dynatrace's 2027 fiscal year. At $915 million, the deal sits well above the FTC's 2026 HSR filing threshold of $133.9 million, triggering mandatory antitrust review and a waiting period before closing. Dynatrace has pointed to an AI observability market it expects to exceed $10 billion by 2030 as the rationale for the price.

What Makes Diligence on an AI Company Different?

Arize's core asset is the methodology it uses to evaluate other companies' AI models, not a product with a clear physical form, which makes ownership harder to pin down than on a standard software deal. DLA Piper's AI practice group had to work out what actually protects that methodology, and what doesn't, before Dynatrace could price the risk of losing it. That question follows the technology through closing, since Dynatrace is buying a process as much as a product.

A Client Relationship Reaching Its Exit

Arize had raised more than $130 million in venture funding, including a $70 million Series C round, before this deal gave its backers an exit. Founder and CEO Jason Lopatecki said joining Dynatrace would let Arize "take that mission much further". Both Arize founders join Dynatrace on closing, with Lopatecki reporting to Dynatrace CEO Rick McConnell rather than departing, pointing to a retention structure built around unvested equity instead of a straightforward pay-out.

Which Practice Areas Does This Involve?

  • Corporate: Will draft and negotiate the purchase agreement itself, then build the cash-versus-equity split into its terms and work through the disclosure schedules that back up every warranty Arize gave.

  • Antitrust: Will prepare and file the HSR notification triggered by the deal's size, then build the case that Dynatrace and Arize sit at different points in the AI pipeline rather than competing head-to-head, in case regulators ask questions during the waiting period.

  • Intellectual Property: Will audit every patent application and invention assignment Arize's engineers had signed, then check whether its evaluation methodology holds up as a trade secret if it turns out not to qualify for patent protection.

  • Insurance: Will negotiate the representation and warranty insurance policy with underwriters, including which exclusions they would accept, so Arize's investors can avoid a multi-year escrow holdback.

  • Employment and Benefits: Will draft the retention agreements that convert verbal promises to Arize's team into contracts, and work through how the two companies' benefits plans line up once the workforces combine.

  • Tax: Will model how the cash-and-equity split gets taxed for Arize's investors, then draft the tax representations and covenants that go into the agreement.

What Happens Next?

Dynatrace expects the deal to add roughly 200 basis points to annual recurring revenue growth while cutting non-GAAP operating margin by about 175 basis points through fiscal 2027, with margin recovering from fiscal 2028 onward. The legal work here mattered less for closing than for what follows: whether Arize's methodology stays defensible once integrated, and whether DLA Piper's retention structure keeps its authors around long enough to matter.